Clinical trial
Double Blind, Placebo Controlled, Crossover Study of Extended Release Methylphenidate for Treatment of ADHD in Children With Epilepsy
NCT00323947 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind, Placebo Controlled, Crossover Study of Extended Release Methylphenidate for Treatment of ADHD in Children With Epilepsy
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2003
- Completion date
- November 30, 2007
- Enrollment
- 33 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.